SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-23-029433
Filing Date
2023-08-18
Accepted
2023-08-18 16:05:30
Documents
12
Period of Report
2023-08-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 73616
  Complete submission text file 0001493152-23-029433.txt   252710

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE evfm-20230810.xsd EX-101.SCH 3009
3 XBRL LABEL FILE evfm-20230810_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE evfm-20230810_pre.xml EX-101.PRE 22355
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 3337
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36754 | Film No.: 231185898
SIC: 2834 Pharmaceutical Preparations